4.7 Article

Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Immune Checkpoint Modulation for Non-Small Cell Lung Cancer

Jean-Charles Soria et al.

CLINICAL CANCER RESEARCH (2015)

Article Oncology

Prognostic value of programed death ligand 1 in patients with solid tumors: A meta-analysis

Ying Jin et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2015)

Review Oncology

PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy

Sandip Pravin Patel et al.

MOLECULAR CANCER THERAPEUTICS (2015)

Review Oncology

Refining the treatment of NSCLC according to histological and molecular subtypes

Anish Thomas et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2015)

Article Medicine, Research & Experimental

Programmed death ligand-1 expression in non-small cell lung cancer

Vamsidhar Velcheti et al.

LABORATORY INVESTIGATION (2014)

Article Medicine, General & Internal

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Marco Gerlinger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, General & Internal

Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer

Suzanne L. Topalian et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)